These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7650876)

  • 1. Effects of serotonin1A agonists on anoxia-induced impairment of protein synthesis in rat brain slices.
    Suzuki M; Matsuda T; Somboonthum P; Asano S; Takuma K; Nogi H; Baba A
    Jpn J Pharmacol; 1995 Apr; 67(4):403-5. PubMed ID: 7650876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the serotonin1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats.
    Sugimoto Y; Yamada J; Kimura I; Watanabe Y; Horisaka K
    Jpn J Pharmacol; 1992 Oct; 60(2):145-8. PubMed ID: 1479742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
    Sharp T; McQuade R; Bramwell S; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress.
    Saphier D; Welch JE
    J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain.
    Okazawa H; Yamane F; Blier P; Diksic M
    J Neurochem; 1999 May; 72(5):2022-31. PubMed ID: 10217280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone raises blood pressure through activation of sympathetic nervous system and by direct activation of alpha1-adrenergic receptors after severe hemorrhage.
    Osei-Owusu P; Scrogin KE
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1132-40. PubMed ID: 14769835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
    Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease.
    Mignon LJ; Wolf WA
    Neuroreport; 2005 May; 16(7):699-703. PubMed ID: 15858409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo.
    Esteban S; Moranta D; Sastre-Coll A; Miralles A; García-Sevilla JA
    Neurosci Lett; 2002 Jun; 326(2):121-4. PubMed ID: 12057843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of orally administered 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole (MKC-242) with 5-HT1A receptors in rat brain.
    Asano S; Matsuda T; Yoshikawa T; Somboonthum P; Tasaki H; Abe M; Baba A
    Jpn J Pharmacol; 1997 May; 74(1):69-75. PubMed ID: 9195299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the serotonin agonists 8-OH-DPAT, buspirone, and DOI on water maze performance.
    Kant GJ; Wylie RM; Chu K; Ghosh S
    Pharmacol Biochem Behav; 1998 Mar; 59(3):729-35. PubMed ID: 9512079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes.
    Sempere T; Urbina M; Lima L
    Neuroimmunomodulation; 2004; 11(5):307-15. PubMed ID: 15316241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic studies in rats of S-8-(2-Furyl)- and R-8-phenyl-2-(di-n-propylamino) tetralin, two novel 5-HT1A receptor agonists in-vitro with different properties in-vivo.
    Yu H; Liu Y; Li HB; Martin AR; Hacksell U; Lewander T
    J Pharm Pharmacol; 1997 Feb; 49(2):169-77. PubMed ID: 9055190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
    Croci T; Landi M; Bianchetti A; Manara L
    Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
    Yu H; Liu Y; Hacksell U; Lewander T
    J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.